These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23910031)

  • 21. Fluarix quadrivalent vaccine for influenza.
    Graaf Hd; Faust SN
    Expert Rev Vaccines; 2015; 14(8):1055-63. PubMed ID: 26098443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
    Belshe RB; Coelingh K; Ambrose CS; Woo JC; Wu X
    Vaccine; 2010 Feb; 28(9):2149-56. PubMed ID: 20003926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolutionary pattern of reemerging influenza B/Victoria lineage viruses in São Paulo, Brazil, 1996-2012: Implications for vaccine composition strategy.
    Paiva TM; Benega MA; Silva DB; Santos KC; Cruz AS; Hortenci MF; Barbieri MT; Monteiro MM; Barbosa HA; Carvalhanas TR
    J Med Virol; 2013 Nov; 85(11):1983-9. PubMed ID: 23926069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live attenuated influenza vaccine tetravalent: a clinical review.
    Bandell AR; Simões EA
    Expert Rev Vaccines; 2015 Jul; 14(7):963-73. PubMed ID: 25864428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine for prevention of mild and moderate-to-severe influenza in children.
    Jain VK; Rivera L; Zaman K; Espos RA; Sirivichayakul C; Quiambao BP; Rivera-Medina DM; Kerdpanich P; Ceyhan M; Dinleyici EC; Cravioto A; Yunus M; Chanthavanich P; Limkittikul K; Kurugol Z; Alhan E; Caplanusi A; Durviaux S; Boutet P; Ofori-Anyinam O; Chandrasekaran V; Dbaibo G; Innis BL
    N Engl J Med; 2013 Dec; 369(26):2481-91. PubMed ID: 24328444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America.
    Jamotte A; Clay E; Macabeo B; Caicedo A; Lopez JG; Bricks L; Romero Prada M; Marrugo R; Alfonso P; Moreno Arévalo B; Franco D; Garcia Diaz L; Isaza de Molto Y
    Hum Vaccin Immunother; 2017 Apr; 13(4):877-888. PubMed ID: 28118092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.
    Camilloni B; Neri M; Lepri E; Iorio AM
    Vaccine; 2009 Jun; 27(31):4099-103. PubMed ID: 19410623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.
    Thommes EW; Kruse M; Kohli M; Sharma R; Noorduyn SG
    Hum Vaccin Immunother; 2017 Apr; 13(4):867-876. PubMed ID: 27858509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.
    Greenberg DP; Robertson CA; Noss MJ; Blatter MM; Biedenbender R; Decker MD
    Vaccine; 2013 Jan; 31(5):770-6. PubMed ID: 23228813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations for prevention and control of influenza in children, 2012-2013.
    Committee on Infectious Diseases, American Academy of Pediatrics
    Pediatrics; 2012 Oct; 130(4):780-92. PubMed ID: 22966032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The 2001/2002 influenza season and the vaccine composition for the 2002/2003 season].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Wilbrink B; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1846-50. PubMed ID: 12382372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis.
    You JH; Ming WK; Chan PK
    Hum Vaccin Immunother; 2015; 11(3):564-71. PubMed ID: 25714506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season].
    de Jong JC; Rimmelzwaan GF; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2007 Sep; 151(39):2158-65. PubMed ID: 17957994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The coming era of quadrivalent human influenza vaccines: who will benefit?
    Barr IG; Jelley LL
    Drugs; 2012 Dec; 72(17):2177-85. PubMed ID: 23110610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations for Prevention and Control of Influenza in Children, 2015-2016.
    Committee on Infectious Diseases, American Academy of Pediatrics
    Pediatrics; 2015 Oct; 136(4):792-808. PubMed ID: 26347430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies.
    Gasparini R; Amicizia D; Lai PL; Panatto D
    J Prev Med Hyg; 2016; 57(1):E1-4. PubMed ID: 27346933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.